"Das Universitätsklinikum des Saarlandes (UKS) ist mit 30 Kliniken und 20 Instituten das medizinische Hochleistungszentrum der Großregion und bietet international vernetzte Spitzenforschung. Jedes Jahr werden über 50.000 Patienten stationär und über 200.000 ambulant versorgt. Als einer der größten Arbeitgeber und Ausbilder des Saarlandes beschäftigen wir über 5 000 Beschäftigte, darunter u. a. 2 000 Pflegekräfte, rund 600 Ärztinnen und Ärzte und über 600 Auszubildende. An der Medizinischen Fakultät des Saarlandes studieren rund 2.000 Studentinnen und Studenten der Fächer Human- und Zahnmedizin, Human- und Molekularbiologie sowie Bioinformatik."

During the past decade, Universität Des Saarlandes conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universität Des Saarlandes" #1 sponsor was "LivaNova" with 2 trials, followed by "Shire" with 2 trials sponsored, "Celgene" with 1 trials sponsored, "Heidelberg University" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universität Des Saarlandes" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "Takeda Development Center Americas, Inc." with 1 trials as a collaborator, "University Hospital Ulm" with 1 trials as a collaborator and "University Medical Center Gießen and Marburg GmbH" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Universität Des Saarlandes" are "Anaplastic Astrocytoma" (1 trials), "Biventricular Tachycardias" (1 trials), "Cytomegalovirus (CMV)" (1 trials), "Fuchs' Endothelial Corneal Dystrophy" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Universität Des Saarlandes" in a lesser frequency.

Most popular intervention types in "Universität Des Saarlandes" are "Drug" (10 trials), "Device" (4 trials), "Other" (2 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abraxane (Induction)" (1 trials), "Abraxane (Maintenance)" (1 trials), "Asacol" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universität Des Saarlandes" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Universität Des Saarlandes". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Universität Des Saarlandes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universität Des Saarlandes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".